These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25503497)

  • 1. Blood ammonia and glutamine as predictors of hyperammonemic crises in patients with urea cycle disorder.
    Lee B; Diaz GA; Rhead W; Lichter-Konecki U; Feigenbaum A; Berry SA; Le Mons C; Bartley JA; Longo N; Nagamani SC; Berquist W; Gallagher R; Bartholomew D; Harding CO; Korson MS; McCandless SE; Smith W; Cederbaum S; Wong D; Merritt JL; Schulze A; Vockley J; Kronn D; Zori R; Summar M; Milikien DA; Marino M; Coakley DF; Mokhtarani M; ; Scharschmidt BF
    Genet Med; 2015 Jul; 17(7):561-8. PubMed ID: 25503497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine and hyperammonemic crises in patients with urea cycle disorders.
    Lee B; Diaz GA; Rhead W; Lichter-Konecki U; Feigenbaum A; Berry SA; Le Mons C; Bartley J; Longo N; Nagamani SC; Berquist W; Gallagher RC; Harding CO; McCandless SE; Smith W; Schulze A; Marino M; Rowell R; Coakley DF; Mokhtarani M; Scharschmidt BF
    Mol Genet Metab; 2016 Jan; 117(1):27-32. PubMed ID: 26586473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the Link: Seizure Characteristics and Ammonia Levels in Urea Cycle Disorder During Hyperammonemic Crises.
    Chanvanichtrakool M; Schreiber JM; Chen WL; Barber J; Zhang A; Ah Mew N; Schulze A; Wilkening G; Nagamani SCS; Gropman A;
    Pediatr Neurol; 2024 Oct; 159():48-55. PubMed ID: 39121557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycerol phenylbutyrate efficacy and safety from an open label study in pediatric patients under 2 months of age with urea cycle disorders.
    Longo N; Diaz GA; Lichter-Konecki U; Schulze A; Inbar-Feigenberg M; Conway RL; Bannick AA; McCandless SE; Zori R; Hainline B; Ah Mew N; Canavan C; Vescio T; Kok T; Porter MH; Berry SA
    Mol Genet Metab; 2021 Jan; 132(1):19-26. PubMed ID: 33388234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycerol phenylbutyrate treatment in children with urea cycle disorders: pooled analysis of short and long-term ammonia control and outcomes.
    Berry SA; Lichter-Konecki U; Diaz GA; McCandless SE; Rhead W; Smith W; Lemons C; Nagamani SC; Coakley DF; Mokhtarani M; Scharschmidt BF; Lee B
    Mol Genet Metab; 2014 May; 112(1):17-24. PubMed ID: 24630270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 2 comparison of a novel ammonia scavenging agent with sodium phenylbutyrate in patients with urea cycle disorders: safety, pharmacokinetics and ammonia control.
    Lee B; Rhead W; Diaz GA; Scharschmidt BF; Mian A; Shchelochkov O; Marier JF; Beliveau M; Mauney J; Dickinson K; Martinez A; Gargosky S; Mokhtarani M; Berry SA
    Mol Genet Metab; 2010 Jul; 100(3):221-8. PubMed ID: 20382058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate.
    Diaz GA; Krivitzky LS; Mokhtarani M; Rhead W; Bartley J; Feigenbaum A; Longo N; Berquist W; Berry SA; Gallagher R; Lichter-Konecki U; Bartholomew D; Harding CO; Cederbaum S; McCandless SE; Smith W; Vockley G; Bart SA; Korson MS; Kronn D; Zori R; Merritt JL; C S Nagamani S; Mauney J; Lemons C; Dickinson K; Moors TL; Coakley DF; Scharschmidt BF; Lee B
    Hepatology; 2013 Jun; 57(6):2171-9. PubMed ID: 22961727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of plasma ammonia and glutamine concentrations in urea cycle disorders.
    Serrano M; Ormazábal A; Vilaseca MA; Lambruschini N; Garcia-Romero R; Meavilla S; Perez-Dueñas B; Pineda M; Garcia-Cazorla A; Campistol J; Artuch R
    Clin Biochem; 2011 Jun; 44(8-9):742-4. PubMed ID: 21497589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term safety and efficacy of glycerol phenylbutyrate for the management of urea cycle disorder patients.
    Diaz GA; Schulze A; Longo N; Rhead W; Feigenbaum A; Wong D; Merritt JL; Berquist W; Gallagher RC; Bartholomew D; McCandless SE; Smith WE; Harding CO; Zori R; Lichter-Konecki U; Vockley J; Canavan C; Vescio T; Holt RJ; Berry SA
    Mol Genet Metab; 2019 Aug; 127(4):336-345. PubMed ID: 31326288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hyperammonaemia in adults not explained by liver disease.
    Walker V
    Ann Clin Biochem; 2012 May; 49(Pt 3):214-28. PubMed ID: 22349554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia.
    Tuchman M; Yudkoff M
    Mol Genet Metab; 1999 Jan; 66(1):10-5. PubMed ID: 9973542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
    Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
    J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders.
    Meyburg J; Opladen T; Spiekerkötter U; Schlune A; Schenk JP; Schmidt J; Weitz J; Okun J; Bürger F; Omran TB; Abdoh G; Al Rifai H; Monavari A; Konstantopoulou V; Kölker S; Yudkoff M; Hoffmann GF
    J Inherit Metab Dis; 2018 Jan; 41(1):81-90. PubMed ID: 29027067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2months to 2years.
    Berry SA; Longo N; Diaz GA; McCandless SE; Smith WE; Harding CO; Zori R; Ficicioglu C; Lichter-Konecki U; Robinson B; Vockley J
    Mol Genet Metab; 2017 Nov; 122(3):46-53. PubMed ID: 28916119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate.
    Smith W; Diaz GA; Lichter-Konecki U; Berry SA; Harding CO; McCandless SE; LeMons C; Mauney J; Dickinson K; Coakley DF; Moors T; Mokhtarani M; Scharschmidt BF; Lee B
    J Pediatr; 2013 Jun; 162(6):1228-34, 1234.e1. PubMed ID: 23324524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
    Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious precipitants of acute hyperammonemia are associated with indicators of increased morbidity in patients with urea cycle disorders.
    McGuire PJ; Lee HS; ; Summar ML
    J Pediatr; 2013 Dec; 163(6):1705-1710.e1. PubMed ID: 24084106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary phenylacetylglutamine as dosing biomarker for patients with urea cycle disorders.
    Mokhtarani M; Diaz GA; Rhead W; Lichter-Konecki U; Bartley J; Feigenbaum A; Longo N; Berquist W; Berry SA; Gallagher R; Bartholomew D; Harding CO; Korson MS; McCandless SE; Smith W; Vockley J; Bart S; Kronn D; Zori R; Cederbaum S; Dorrani N; Merritt JL; Sreenath-Nagamani S; Summar M; Lemons C; Dickinson K; Coakley DF; Moors TL; Lee B; Scharschmidt BF
    Mol Genet Metab; 2012 Nov; 107(3):308-14. PubMed ID: 22958974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of NO cycle coupling with urea cycle in non-hyperammonemic carriers of ornithine transcarbamylase deficiency.
    Nagasaka H; Yorifuji T; Egawa H; Inui A; Fujisawa T; Komatsu H; Tsukahara H; Uemoto S; Inomata Y
    Mol Genet Metab; 2013 Jul; 109(3):251-4. PubMed ID: 23669167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between longitudinal changes in neuropsychological outcome and disease biomarkers in urea cycle disorders.
    Lichter-Konecki U; Sanz JH; ; McCarter R
    Pediatr Res; 2023 Dec; 94(6):2005-2015. PubMed ID: 37454183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.